DLD Asset Management, LP - CONATUS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 34 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
DLD Asset Management, LP ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$3,000
-99.7%
11,700
-98.9%
0.00%
-100.0%
Q1 2019$1,113,000
-26.9%
1,030,200
+17.1%
0.04%
-60.6%
Q4 2018$1,522,000
-24.7%
879,900
+152.6%
0.10%
+4.0%
Q3 2018$2,020,000–348,300–0.10%–
 Download
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders